Bruno Sangro, MD, PhD, discusses the key takeaways from recent data in the treatment landscape of patients with hepatocellular carcinoma.
Videos
Dr Robert Dreicer reviews a case of advanced urothelial cancer and explains the patient’s eligibility for platinum-based chemotherapy followed by maintenance therapy with a checkpoint inhibitor.
Uday R. Popat, MD, discusses the role of ruxolitinib as treatment of patients with graft-versus-host-disease.
Noopur S. Raje, MD, discusses the results of the BOSTON trial of selinexor, bortezomib, and dexamethasone in patients with multiple myeloma.
Experts in breast oncology review 3 clinical cases of HER2+ breast cancer and discuss individualized treatment approaches for each patient.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Early CAR T Brings Questions of Preferred Bridging in Multiple Myeloma
2
FDA Grants Rare Pediatric Disease Designation to Opaganib for Neuroblastoma
3
FDA Grants RMAT Designation to Lasme-Cel for Relapsed/Refractory B-ALL
4
ASCO 2026 Highlights: Breast & Lung Cancer Advances With Ajaz Khan, MD
5